Literature DB >> 23696617

Aromatase inhibitors induce 'male pattern hair loss' in women?

A Rossi, A Iorio, E Scali, M C Fortuna, E Mari, C Maxia, M Gerardi, M Framarino, M Carlesimo.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2013        PMID： 23696617     DOI： 10.1093/annonc/mdt170

Source DB:  PubMed          Journal:  Ann Oncol        ISSN： 0923-7534            Impact factor:   32.976


× No keyword cloud information.
  10 in total

Review 1.  Chemotherapy-induced alopecia management: Clinical experience and practical advice.

Authors:  Alfredo Rossi; Maria Caterina Fortuna; Gemma Caro; Giulia Pranteda; Valentina Garelli; Umberto Pompili; Marta Carlesimo
Journal:  J Cosmet Dermatol       Date:  2017-02-02       Impact factor: 2.696

Review 2.  Safety of 5α-reductase inhibitors and spironolactone in breast cancer patients receiving endocrine therapies.

Authors:  Raquel N Rozner; Azael Freites-Martinez; Jerry Shapiro; Eliza B Geer; Shari Goldfarb; Mario E Lacouture
Journal:  Breast Cancer Res Treat       Date:  2018-11-22       Impact factor: 4.872

Review 3.  Hair disorders in cancer survivors.

Authors:  Azael Freites-Martinez; Jerry Shapiro; Corina van den Hurk; Shari Goldfarb; Joaquin J Jimenez; Anthony M Rossi; Ralf Paus; Mario E Lacouture
Journal:  J Am Acad Dermatol       Date:  2018-04-14       Impact factor: 11.527

4.  Endocrine Therapy-Induced Alopecia in Patients With Breast Cancer.

Authors:  Azael Freites-Martinez; Jerry Shapiro; Donald Chan; Monica Fornier; Shanu Modi; Devika Gajria; Stephen Dusza; Shari Goldfarb; Mario E Lacouture
Journal:  JAMA Dermatol       Date:  2018-06-01       Impact factor: 10.282

Review 5.  Management of hair loss associated with endocrine therapy in patients with breast cancer: an overview.

Authors:  Fatih Karatas; Suleyman Sahin; Ali R Sever; Kadri Altundag
Journal:  Springerplus       Date:  2016-05-10

6.  Persistent major alopecia following adjuvant docetaxel for breast cancer: incidence, characteristics, and prevention with scalp cooling.

Authors:  M Martín; J C de la Torre-Montero; S López-Tarruella; K Pinilla; A Casado; S Fernandez; Y Jerez; J Puente; I Palomero; R González Del Val; M Del Monte-Millan; T Massarrah; C Vila; B García-Paredes; J A García-Sáenz; A Lluch
Journal:  Breast Cancer Res Treat       Date:  2018-06-19       Impact factor: 4.872

Review 7.  Art of prevention: The importance of dermatologic care when using aromatase inhibitors.

Authors:  Sara Behbahani; Amaris Geisler; Avani Kolla; Margaret Rush Dreker; Genevieve Kaunitz; Miriam K Pomeranz
Journal:  Int J Womens Dermatol       Date:  2021-07-17

Review 8.  Clinical aspect, pathogenesis and therapy options of alopecia induced by hormonal therapy for breast cancer.

Authors:  Alfredo Rossi; Gemma Caro; Francesca Magri; Maria Caterina Fortuna; Marta Carlesimo
Journal:  Explor Target Antitumor Ther       Date:  2021-10-31

Review 9.  Dermatologic conditions in women receiving systemic cancer therapy.

Authors:  Michelle N Ferreira; Julie Y Ramseier; Jonathan S Leventhal
Journal:  Int J Womens Dermatol       Date:  2019-11-07

Review 10.  The Potential Role of Nutraceuticals as an Adjuvant in Breast Cancer Patients to Prevent Hair Loss Induced by Endocrine Therapy.

Authors:  Giorgio Dell'Acqua; Aleksander Richards; M Julie Thornton
Journal:  Nutrients       Date:  2020-11-18       Impact factor: 5.717
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.